Gambro first-half profits jump 18 percent 
Swedish pharmaceutical group Gambro on Friday reported an 18 percent
rise in pre-tax profits in the first half of 1994, to 582 million
kronor (75 million dollars) against 495 million kronor (63 million
dollars) in 1992.
Operating income improved by 9 percent to 723 million kronor (92.6
million dollars) from 664 million kronor (85 million dollars) in the
same period last year.
Sales during the first six months rose to 4.88 billion kronor (625.6
million dollars), compared to 4.32 billion kronor (554 million dollars)
during the corresponding period last year.
